Kristen Stoltz

Title: Kristen Stoltz: Innovator in Kinase Inhibitors

Introduction

Kristen Stoltz is a prominent inventor based in Waltham, MA (US). She has made significant contributions to the field of biochemistry, particularly in the development of kinase inhibitors. Her work focuses on innovative methods for treating diseases associated with specific kinases.

Latest Patents

Kristen Stoltz holds a patent for "GCN2 and PERK kinase inhibitors and methods of use thereof." This patent describes compounds that are inhibitors of GCN2 kinase or PERK kinase. The compounds include various forms such as pharmaceutically acceptable salts, enantiomers, stereoisomers, and tautomers. The methods outlined in her patent aim to treat diseases linked to GCN2 kinase or PERK kinase.

Career Highlights

Kristen Stoltz is currently employed at Deciphera Pharmaceuticals, LLC, where she continues her research and development efforts. Her work at Deciphera has positioned her as a key player in the pharmaceutical industry, particularly in the area of kinase inhibitors.

Collaborations

Some of her notable coworkers include Daniel L Flynn and Patrick Kearney. Their collaborative efforts contribute to the innovative research environment at Deciphera Pharmaceuticals.

Conclusion

Kristen Stoltz is a dedicated inventor whose work in kinase inhibitors has the potential to impact the treatment of various diseases. Her contributions to the field exemplify the importance of innovation in biochemistry and pharmaceuticals.